The observation that TG2-179-1 still killed BAP1-insensitive colon cancer cells (HCT15 and LoVo) raised the question of whether TG2-179-1 exerts its cytotoxic activity by targeting BAP1. The gene discussed is BAP1; the disease is malignant colon neoplasm.